AlzChem presses ahead with €219m Frankfurt IPO

By Aidan Gregory
26 Jan 2017

AlzChem, the German speciality chemicals maker, has set the terms for the first Frankfurt IPO of 2017.

Société Générale and Baader Bank are global co-ordinators.

The price range has been set at €20-€27 a share. With up to 8.1m shares on offer, the deal will be worth €162m-€219.5m assuming the greenshoe is exercised.

AlzChem will have a free float of 62.5% including ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.